Preferred Label : Miyoshi muscular dystrophy 1;
Symbol : MMD1;
CISMeF acronym : MMD1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Muscular dystrophy, distal, late-onset, autosomal recessive; Miyoshi myopathy;
Description : Miyoshi muscular dystrophy is an autosomal recessive skeletal muscle disorder characterized
by onset in young adulthood of distal muscle weakness affecting the upper and lower
limbs but sparing the intrinsic hand muscles. Muscle weakness and atrophy particularly
affects the gastrocnemius and soleus muscles, and can later spread to involve the
thigh and gluteal muscles. Patients showed impaired tip-toe standing, difficulty in
climbing stairs, and difficulty walking, but usually remain ambulatory. Serum creatine
kinase is increased and muscle biopsies show myopathic and dystrophic changes with
necrosis (summary by Miyoshi et al., 1986). - Genetic Heterogeneity of Miyoshi Muscular
Dystrophy Miyoshi muscular dystrophy is a genetically heterogeneous disorder: MMD2
(613318) has been mapped to chromosome 10p, and MMD3 (613319) is caused by mutation
in the ANO5 gene (608662) on chromosome 11p14. See also Welander myopathy (604454),
an autosomal dominant form of late-onset distal myopathy.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the dysferlin gene (DYS, 603009.0001);
Laboratory abnormalities : Increased creatine kinase;
Prefixed ID : #254130;
Origin ID : 254130;
UMLS CUI : C4551973;
- Currated CISMeF NLP mapping
- DO Cross reference
- Genes related to phenotype
- HPO term(s)
- ORDO concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT